Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/10/2009CN101450049A Pharmaceutical composition
06/10/2009CN101450048A Acute hypoxia injury resistance use of teprenone
06/10/2009CN101450047A Use of black mulberry extract as tyrosinase inhibitor
06/10/2009CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof
06/10/2009CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
06/10/2009CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
06/10/2009CN100497379C Protein complex serving as vehicle for orally administerable medicaments
06/10/2009CN100497362C Aminoglucose acid, chromium complex with its derivative and preparation and use thereof
06/10/2009CN100497356C Crystalline forms of adefovir dipivoxil ester
06/10/2009CN100497346C Chemokine CCR5 receptor modulators
06/10/2009CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists
06/10/2009CN100497334C Indole derivatives useful as histamine h3 antagonists
06/10/2009CN100497333C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
06/10/2009CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
06/10/2009CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof
06/10/2009CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/10/2009CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them
06/10/2009CN100497302C Diarylurea derivatives and their use as chloride channel blockers
06/10/2009CN100496608C Medical aerosol formulations
06/10/2009CN100496607C Combination of a NSAID and a PDE-4 inhibitor
06/10/2009CN100496508C Policresulen gelling agent, method for preparation the same and the pharmaceutical use thereof
06/10/2009CN100496507C Hydroxyethyl starch injection liquid and preparation method thereof
06/10/2009CN100496506C Puerarin injection
06/10/2009CN100496505C Nano emulsion containing ginsenoside, preparation method and usage
06/10/2009CN100496504C Medicinal water-soluble compositions containing 20(R)-ginsenoside (Rg3), and its preparation method
06/10/2009CN100496503C Nano emulsion containing ginsenoside, preparation method and usage
06/10/2009CN100496502C Preparation method of capsule drop for protecting eye
06/10/2009CN100496501C Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
06/10/2009CN100496500C Remedies for glaucoma comprising bunazosin and prostaglandins
06/10/2009CN100496499C Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein
06/10/2009CN100496498C Medicinal composition containing enalapril or genazepril and sotalol
06/10/2009CN100496497C Theophylline chitin micro-balls slow-release preparation, and its preparation method
06/10/2009CN100496496C Compound metformin glipidide preparation for treating diabetes type II, and its preparation method
06/10/2009CN100496495C Remedies and/or preventives for diabetic ischemic heart diseases
06/10/2009CN100496494C Drop pills of amlodipine maleate and preparation method thereof
06/10/2009CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives
06/10/2009CN100496492C Medendazole new formulation for treating chronic nasosinusitis
06/10/2009CN100496491C Mebendazole new formulation for treating chronic rhinitis
06/10/2009CN100496490C Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
06/10/2009CN100496489C Nizofenone fumarate freeze-dried powder and method of preparing the same
06/10/2009CN100496488C Tinidazole vaginal soft capsule and its preparing method
06/10/2009CN100496487C Mitiglinide preparation and preparing method
06/10/2009CN100496486C Hard-soluble medicine release-controlled formulation
06/10/2009CN100496485C Antineoplastic combinations
06/10/2009CN100496484C Liquid vitamic C compounded nanometer elementary selenium, its preparation method and storage method
06/10/2009CN100496483C Ligustilide cyclodextrin or its derivatives inclusion compound, its preparation method and pharmaceutical formulation
06/10/2009CN100496482C Application of ligustilide in preparation of medicine for preventing and treating cerebral ischemia diseases
06/10/2009CN100496481C Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method
06/10/2009CN100496480C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
06/10/2009CN100496479C Application of (R)- flurbiprofenester in pharmacy
06/10/2009CN100496478C Use of hydroxyoleic acid and related compounds as functional food additives
06/10/2009CN100496477C Composite tramadol hydrochloride formulation and preparation process thereof
06/10/2009CN100496476C Novel use of peptide compounds for treating central neuropathic pain
06/10/2009CN100496475C Xinjiang ferula essence, its preparation process and application in pharmacy
06/10/2009CN100496474C Oral percarbonateamide oxygen-supply agent and preparation thereof
06/10/2009CN100496473C A medicine for treating dryness heat exuberance type diabetes
06/10/2009CN100496472C Topical compositions and methods for treating pain
06/10/2009CN100496471C Dithranol stick
06/10/2009CN100496470C Use of polyphenol and its oxides
06/10/2009CN100496458C Method of forming aerosol for inhalation delivery
06/10/2009CN100496448C Oil-in-water emulsion composition
06/10/2009CN100496244C Nodulisporic acid derivative spot-on formulations for killing parasites
06/09/2009US7544859 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits
06/09/2009US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis
06/09/2009US7544816 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin
06/09/2009US7544814 lactam fermentation products; pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane; based on marine microorganisms structures; cytotoxicity, NF- kappa B inhibition, and caspase-like and trypsin-like proteasome inhibition
06/09/2009US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus
06/09/2009US7544808 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
06/09/2009US7544806 Piperidine-substituted indoles-or heteroderivatives thereof
06/09/2009US7544805 Hydrophobic; storage stability; coprecipitate of amorphous montelukast sodium and lactose prepared by freeze-drying and pressing at 10,000 Kg/cm3 for 1 minute; spray drying from an aqueous solution; relatively high bulk density; materials handling
06/09/2009US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
06/09/2009US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides
06/09/2009US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor
06/09/2009US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes
06/09/2009US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease
06/09/2009US7544715 Tumor imaging compounds
06/09/2009US7544714 Lipid-amino acid conjugates and methods of use
06/09/2009US7544713 Compounds and methods for delivery of prostacyclin analogs
06/09/2009US7544712 Treatment of coronavirus infection
06/09/2009US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
06/09/2009US7544710 Strontium ranelate for use in the treatment of gastro-duodenal pain and especially gastritis and duodenitis and any inflammation of the mucosa of the stomach whether acute or chronic
06/09/2009US7544709 Derivatives of andrimide and moiramide B having antibacterial properties
06/09/2009US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
06/09/2009US7544707 Peroxisome Proliferator Activated Receptor (PPAR); 2-Methyl-4-[2-(4-trifluoromethylphenyl)-2H-indazol-7-ylmethylsulfanyl]phenoxyacetic Acid; diabetes, Metabolic and cardiovascular disorders, arthritis, demyelinating diseases
06/09/2009US7544706 Substituted imidazoles
06/09/2009US7544705 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
06/09/2009US7544704 Aryl-4-ethynyl-isoxazole derivatives
06/09/2009US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/09/2009US7544702 Bisaryl-sulfonamides
06/09/2009US7544701 Central nervous system disorders; psychological disorders
06/09/2009US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders
06/09/2009US7544699 Aryl and heteroaryl compounds, compositions, and methods of use
06/09/2009US7544698 Indoles and benzoimidazoles as modulators of the histamine H4 receptor
06/09/2009US7544697 Pyrazolopyridines and analogs thereof
06/09/2009US7544696 Spermicidal and/or antifungal composition and methods of using the same
06/09/2009US7544695 N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; inhibit histone deacetylase, selectively induce terminal differentiation and arresting cell growth and/or apoptosis of neoplastic cells; increased bioavailability
06/09/2009US7544694 Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
06/09/2009US7544693 Spirofuropyridine aryl derivatives
06/09/2009US7544692 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus
06/09/2009US7544691 Guanidine derivatives
1 ... 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 ... 7860